When.com Web Search

  1. Ads

    related to: does simvastatin really work for sleep problem students free trial

Search results

  1. Results From The WOW.Com Content Network
  2. Simvastatin - Wikipedia

    en.wikipedia.org/wiki/Simvastatin

    Simvastatin, sold under the brand name Zocor among others, is a statin, a type of lipid-lowering medication. [4] It is used along with exercise, diet, and weight loss to decrease elevated lipid levels . [ 4 ]

  3. Scandinavian Simvastatin Survival Study - Wikipedia

    en.wikipedia.org/wiki/Scandinavian_Simvastatin...

    The Scandinavian Simvastatin Survival Study (also known as the 4S study), was a multicentre, randomized, double-blind, placebo-controlled clinical trial, which provided the initial data that supported the use of the cholesterol-lowering drug, simvastatin, in people with a moderately raised cholesterol and coronary heart disease (CHD); that is people who had previously had a heart attack or angina.

  4. Drugs You Don't Need For Disorders You Don't Have - The ...

    highline.huffingtonpost.com/articles/en/sleep...

    Like most other sleep drugs, Belsomra provides only mild relief. “Clinically meaningless” is the way one sleep expert, Gregg Jacobs from the University of Massachusetts Medical School, described Belsomra’s effects. “Almost none of the patients I see are taking Belsomra because it does not work,” Jacobs said.

  5. Lipid-lowering agent - Wikipedia

    en.wikipedia.org/wiki/Lipid-lowering_agent

    In studies using standard doses, statins have been found to lower LDL-C by 18% to 55%, depending on the specific statin being used. A risk exists of muscle damage (myopathy and rhabdomyolysis) with statins. Hypercholesterolemia is not a risk factor for mortality in persons older than 70 years and risks from statin drugs are more increased after ...

  6. Lilly's weight-loss drug reduces sleep apnea severity ... - AOL

    www.aol.com/news/eli-lillys-weight-loss-drug...

    (Reuters) -Eli Lilly said on Wednesday its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials, paving the way ...

  7. Ezetimibe/simvastatin - Wikipedia

    en.wikipedia.org/wiki/Ezetimibe/simvastatin

    With median follow-up of 6 years, simvastatin+ezetimibe was found to reduce the primary outcome of CV mortality, major CV event, or nonfatal stroke (34.7% vs. 32.7%; P=0.016; NNT 50 per 7 years or NNT 350 per 1 year ). There was no reduction in all-cause or CV mortality with simvastatin+ezetimibe, though there was a reduction in MI and stroke. [6]